Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Predictable Irreversible Switching Between Acute and Chronic Inflammation.

Abudukelimu A, Barberis M, Redegeld FA, Sahin N, Westerhoff HV.

Front Immunol. 2018 Aug 7;9:1596. doi: 10.3389/fimmu.2018.01596. eCollection 2018.

2.

Learning to read and write in evolution: from static pseudoenzymes and pseudosignalers to dynamic gear shifters.

Abudukelimu A, Mondeel TDGA, Barberis M, Westerhoff HV.

Biochem Soc Trans. 2017 Jun 15;45(3):635-652. doi: 10.1042/BST20160281. Review.

PMID:
28620026
3.

Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation.

Groot Kormelink T, Powe DG, Kuijpers SA, Abudukelimu A, Fens MH, Pieters EH, Kassing van der Ven WW, Habashy HO, Ellis IO, Blokhuis BR, Thio M, Hennink WE, Storm G, Redegeld FA, Schiffelers RM.

Oncotarget. 2014 May 30;5(10):3159-67.

4.

Measles outbreak on a college campus transmitted through internet caf├ęs.

Jin Y, Ma H, Zhang L, He H, Yisimaer M, Chen M, Rui B, Axigeburen B, Hao J, Sun M, Gao F, Chen W, Abudukelimu A, Chen J, Li Q, Shen M, Shi Y, Hezati Z, Li T, Chen H, Chen J, Zhu BP.

J Infect Dis. 2011 Jul;204 Suppl 1:S471-5. doi: 10.1093/infdis/jir069.

PMID:
21666202
5.

Mast cells as target in cancer therapy.

Groot Kormelink T, Abudukelimu A, Redegeld FA.

Curr Pharm Des. 2009;15(16):1868-78. Review.

PMID:
19519429

Supplemental Content

Loading ...
Support Center